OLIN Corp (OLN) stock
OLNNYSEChemicals & Allied ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 10/3052% below fair value
$17.89+0.39 (+2.23%)
Close on Nov 11, 2026Market cap $2.04BP/E –Yield –
OLIN EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
OLIN's EPS for the twelve months ending Sep 30, 2026 was -$2.00, down 534.8% year over year. For fiscal 2025 it was -$0.88, down 196.7% from the year before. The highest annual figure on record is $8.94 in fiscal 2022.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$0.88 | -196.7% |
| FY2024 | Dec 31, 2024 | $0.91 | -74.5% |
| FY2023 | Dec 31, 2023 | $3.57 | -60.1% |
| FY2022 | Dec 31, 2022 | $8.94 | +12.3% |
| FY2021 | Dec 31, 2021 | $7.96 | – |
| FY2020 | Dec 31, 2020 | -$6.14 | – |
| FY2019 | Dec 31, 2019 | -$0.07 | -103.6% |
| FY2018 | Dec 31, 2018 | $1.95 | -40.2% |
| FY2017 | Dec 31, 2017 | $3.26 | – |
| FY2016 | Dec 31, 2016 | -$0.02 | – |
| FY2015 | Dec 31, 2015 | -$0.01 | -100.8% |
| FY2014 | Dec 31, 2014 | $1.33 | -39.8% |
| FY2013 | Dec 31, 2013 | $2.21 | +19.5% |
| FY2012 | Dec 31, 2012 | $1.85 | -38.1% |
| FY2011 | Dec 31, 2011 | $2.99 | +269.1% |
| FY2010 | Dec 31, 2010 | $0.81 | -53.2% |
| FY2009 | Dec 31, 2009 | $1.73 | -16.4% |
| FY2008 | Dec 31, 2008 | $2.07 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $0.13 | -64.9% |
| Q2 FY2026 | Jun 30, 2026 | -$0.12 | – |
| Q1 FY2026 | Mar 31, 2026 | -$0.73 | -7400.0% |
| Q4 FY2025 | Dec 31, 2025 | -$1.28 | -1522.2% |
| Q3 FY2025 | Sep 30, 2025 | $0.37 | – |
| Q2 FY2025 | Jun 30, 2025 | -$0.01 | -101.6% |
| Q1 FY2025 | Mar 31, 2025 | $0.01 | -97.5% |
| Q4 FY2024 | Dec 31, 2024 | $0.09 | -79.1% |
| Q3 FY2024 | Sep 30, 2024 | -$0.21 | -125.6% |
| Q2 FY2024 | Jun 30, 2024 | $0.62 | -45.1% |
| Q1 FY2024 | Mar 31, 2024 | $0.40 | -65.5% |
| Q4 FY2023 | Dec 31, 2023 | $0.43 | -69.7% |
| Q3 FY2023 | Sep 30, 2023 | $0.82 | -62.4% |
| Q2 FY2023 | Jun 30, 2023 | $1.13 | -59.1% |
| Q1 FY2023 | Mar 31, 2023 | $1.16 | -53.2% |
| Q4 FY2022 | Dec 31, 2022 | $1.42 | -24.5% |
| Q3 FY2022 | Sep 30, 2022 | $2.18 | -8.4% |
| Q2 FY2022 | Jun 30, 2022 | $2.76 | +27.2% |
| Q1 FY2022 | Mar 31, 2022 | $2.48 | +64.2% |
| Q4 FY2021 | Dec 31, 2021 | $1.88 | – |
| Q3 FY2021 | Sep 30, 2021 | $2.38 | – |
| Q2 FY2021 | Jun 30, 2021 | $2.17 | – |
| Q1 FY2021 | Mar 31, 2021 | $1.51 | – |
| Q4 FY2020 | Dec 31, 2020 | -$0.21 | – |
| Q3 FY2020 | Sep 30, 2020 | -$4.67 | -1829.6% |
| Q2 FY2020 | Jun 30, 2020 | -$0.76 | – |
| Q1 FY2020 | Mar 31, 2020 | -$0.51 | -304.0% |
| Q4 FY2019 | Dec 31, 2019 | -$0.49 | -253.1% |
| Q3 FY2019 | Sep 30, 2019 | $0.27 | -76.7% |
| Q2 FY2019 | Jun 30, 2019 | -$0.12 | -134.3% |
| Q1 FY2019 | Mar 31, 2019 | $0.25 | +108.3% |
| Q4 FY2018 | Dec 31, 2018 | $0.32 | -88.9% |
| Q3 FY2018 | Sep 30, 2018 | $1.16 | +274.2% |
| Q2 FY2018 | Jun 30, 2018 | $0.35 | – |
| Q1 FY2018 | Mar 31, 2018 | $0.12 | +50.0% |
| Q4 FY2017 | Dec 31, 2017 | $2.89 | +2790.0% |
| Q3 FY2017 | Sep 30, 2017 | $0.31 | – |
| Q2 FY2017 | Jun 30, 2017 | -$0.04 | – |
| Q1 FY2017 | Mar 31, 2017 | $0.08 | – |
| Q4 FY2016 | Dec 31, 2016 | $0.10 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?